Add to ORKGCopyright © 2015 Dhanya Vasudevan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Aim. Paclitaxel based neoadjuvant chemotherapy regimen (NAT) in the setting of locally advanced breast cancer (LABC) can render inoperable tumor (T4, N2/N3) resectable. The aim of this study was to assess the status of carcinoma in the breast and lymph nodes after paclitaxel based NAT in order to find out the patient and the tumor characteristics that correspond to the pathological responseswhich could be used as a surrogate biomarker to assess the treatment response.Materials andMethods. ...
Background:Neoadjuvant chemotherapy (NACT) treatment has become the standard treatment for locally a...
WOS: 000461427200001PubMed ID: 30814840Neoadjuvant therapy, where patients receive systemic therapy ...
Objective. To study the effect of a pathological complete response (pCR) of the tumor after neoadjuv...
Aim. Paclitaxel based neoadjuvant chemotherapy regimen (NAT) in the setting of locally advanced brea...
Background: Neoadjuvant chemotherapy administered pre-operatively is the standard of care therapy fo...
Background. Tumor response to neoadjuvantchemyotherapy (NACT) in breast cancer is determined using c...
The Author(s) 2014. This article is published with open access at Springerlink.com Abstract To ident...
Background. This study was conducted to determine the impact of neoadjuvant chemotherapy (NAC) on th...
BACKGROUND: The use of neoadjuvant chemotherapy in treating breast cancer has shown efficacy in down...
Copyright © 2012 Mohamed I. El-sayed et al. This is an open access article distributed under the Cre...
Full list of author information is available at the end of the articleIntroduction Neoadjuvant chemo...
Background: Neoadjuvant chemotherapy (NACT) treatment has become the standard treatment for locally ...
Objective: Patients with breast cancer with a pathological complete response (pCR) after neoadjuvant...
BACKGROUND: Locally advanced breast cancer (LABC) occurs relatively infrequently and poses a signif...
Increasing use of neoadjuvant therapy in large tumors or node positive disease in breast cancer pati...
Background:Neoadjuvant chemotherapy (NACT) treatment has become the standard treatment for locally a...
WOS: 000461427200001PubMed ID: 30814840Neoadjuvant therapy, where patients receive systemic therapy ...
Objective. To study the effect of a pathological complete response (pCR) of the tumor after neoadjuv...
Aim. Paclitaxel based neoadjuvant chemotherapy regimen (NAT) in the setting of locally advanced brea...
Background: Neoadjuvant chemotherapy administered pre-operatively is the standard of care therapy fo...
Background. Tumor response to neoadjuvantchemyotherapy (NACT) in breast cancer is determined using c...
The Author(s) 2014. This article is published with open access at Springerlink.com Abstract To ident...
Background. This study was conducted to determine the impact of neoadjuvant chemotherapy (NAC) on th...
BACKGROUND: The use of neoadjuvant chemotherapy in treating breast cancer has shown efficacy in down...
Copyright © 2012 Mohamed I. El-sayed et al. This is an open access article distributed under the Cre...
Full list of author information is available at the end of the articleIntroduction Neoadjuvant chemo...
Background: Neoadjuvant chemotherapy (NACT) treatment has become the standard treatment for locally ...
Objective: Patients with breast cancer with a pathological complete response (pCR) after neoadjuvant...
BACKGROUND: Locally advanced breast cancer (LABC) occurs relatively infrequently and poses a signif...
Increasing use of neoadjuvant therapy in large tumors or node positive disease in breast cancer pati...
Background:Neoadjuvant chemotherapy (NACT) treatment has become the standard treatment for locally a...
WOS: 000461427200001PubMed ID: 30814840Neoadjuvant therapy, where patients receive systemic therapy ...
Objective. To study the effect of a pathological complete response (pCR) of the tumor after neoadjuv...